Enovix (NASDAQ:ENVX) Reaches New 12-Month Low - What's Next?

Key Points

• Enovix shares fell to a new 52-week low of $2.33, last trading near $2.35 versus a prior close of $2.49. The stock remains below its 50-day and 200-day moving averages of $3.13 and $4.99, respectively.
• Analyst sentiment remains mixed but leans positive, with a consensus “Moderate Buy” rating and a $10.77 target price. Recent changes included TD Cowen upgrading the stock to “Hold,” while B. Riley cut its target to $9.
• Enovix exceeded quarterly expectations with a $0.13 adjusted loss per share versus an expected $0.15 loss and revenue of $9.02 million, up 20.8% year over year. However, the company continues to report substantial losses, including a negative net margin of 473.89%.

Enovix Corporation (NASDAQ:ENVX - Get Free Report) reached a new 52-week low during mid-day trading on Tuesday. The company traded as low as $2.33 and last traded at $2.35, with a volume of 7,421,824 shares traded. The stock had previously closed at $2.49.

Analyst Ratings Changes

Several analysts have commented on ENVX shares. TD Cowen raised shares of Enovix to a "hold" rating in a research report on Monday, October 5th. B. Riley Financial reduced their target price on shares of Enovix from $10.00 to $9.00 and set a "buy" rating for the company in a research report on Thursday, August 13th. Northland Securities set a $5.00 target price on shares of Enovix in a research report on Tuesday, October 13th. William Blair lowered shares of Enovix from an "outperform" rating to a "market perform" rating in a research note on Monday, August 17th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $25.00 price target on shares of Enovix in a report on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $10.77.

Enovix Price Performance

The business has a fifty day moving average of $3.13 and a 200-day moving average of $4.99. The firm has a market cap of $515.71 million, a PE ratio of -2.90 and a beta of 2.49. The company has a current ratio of 9.71, a quick ratio of 9.37 and a debt-to-equity ratio of 2.46.

Enovix (NASDAQ:ENVX - Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.02. The business had revenue of $9.02 million during the quarter, compared to the consensus estimate of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The firm's revenue was up 20.8% compared to the same quarter last year. During the same quarter last year, the company earned ($0.13) EPS. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. As a group, research analysts predict that Enovix Corporation will post -0.79 earnings per share for the current year.

Institutional Investors Weigh In On Enovix

Institutional investors and hedge funds have recently modified their holdings of the company. Sax Wealth Advisors LLC purchased a new position in Enovix during the third quarter valued at approximately $29,000. Caitong International Asset Management Co. Ltd bought a new stake in Enovix during the 4th quarter worth approximately $30,000. Calamos Advisors LLC bought a new stake in Enovix during the 1st quarter worth approximately $60,000. Sequoia Financial Advisors LLC purchased a new stake in Enovix in the 2nd quarter worth approximately $61,000. Finally, Gateway Wealth Partners LLC purchased a new stake in Enovix in the 1st quarter worth approximately $68,000. 50.92% of the stock is owned by hedge funds and other institutional investors.

Enovix Company Profile

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company's design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.